(2Z)-2-(3H-1,3-benzothiazol-2-ylidene)-2-[2-[3-(4-methylpiperazin-1-yl)propylamino]pyrimidin-4-yl]acetonitrile

C21H25N7S — CID 11181791

IUPAC(2Z)-2-(3H-1,3-benzothiazol-2-ylidene)-2-[2-[3-(4-methylpiperazin-1-yl)propylamino]pyrimidin-4-yl]acetonitrile
SMILESCN1CCN(CCCNc2nccc(/C(C#N)=C3\Nc4ccccc4S3)n2)CC1
InChIInChI=1S/C21H25N7S/c1-27-11-13-28(14-12-27)10-4-8-23-21-24-9-7-17(26-21)16(15-22)20-25-18-5-2-3-6-19(18)29-20/h2-3,5-7,9,25H,4,8,10-14H2,1H3,(H,23,24,26)/b20-16+
InChIKeyBGZZNMJHBQOPLQ-CAPFRKAQSA-N
MW407.55 g/mol
LogP2.94
Rot. Bonds6

About (2Z)-2-(3H-1,3-benzothiazol-2-ylidene)-2-[2-[3-(4-methylpiperazin-1-yl)propylamino]pyrimidin-4-yl]acetonitrile

(2Z)-2-(3H-1,3-benzothiazol-2-ylidene)-2-[2-[3-(4-methylpiperazin-1-yl)propylamino]pyrimidin-4-yl]acetonitrile (PubChem CID 11181791) has the molecular formula C21H25N7S and a molecular weight of 407.55 g/mol. Its IUPAC name is (2Z)-2-(3H-1,3-benzothiazol-2-ylidene)-2-[2-[3-(4-methylpiperazin-1-yl)propylamino]pyrimidin-4-yl]acetonitrile.

Molecular Properties

Compound Name(2Z)-2-(3H-1,3-benzothiazol-2-ylidene)-2-[2-[3-(4-methylpiperazin-1-yl)propylamino]pyrimidin-4-yl]acetonitrile
PubChem CID11181791
Molecular FormulaC21H25N7S
Molecular Weight407.55 g/mol
Exact Mass407.19
IUPAC Name(2Z)-2-(3H-1,3-benzothiazol-2-ylidene)-2-[2-[3-(4-methylpiperazin-1-yl)propylamino]pyrimidin-4-yl]acetonitrile
SMILESCN1CCN(CCCNc2nccc(/C(C#N)=C3\Nc4ccccc4S3)n2)CC1
InChIInChI=1S/C21H25N7S/c1-27-11-13-28(14-12-27)10-4-8-23-21-24-9-7-17(26-21)16(15-22)20-25-18-5-2-3-6-19(18)29-20/h2-3,5-7,9,25H,4,8,10-14H2,1H3,(H,23,24,26)/b20-16+
InChIKeyBGZZNMJHBQOPLQ-CAPFRKAQSA-N
XLogP2.94
TPSA80.11 Ų
H-Bond Donors2
H-Bond Acceptors8
Rotatable Bonds6
Heavy Atoms29
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500407.55
LogP ≤ 52.94
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 108

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'conjugated_nitrile_group', 'substructure': 'N/A'}

Analyze (2Z)-2-(3H-1,3-benzothiazol-2-ylidene)-2-[2-[3-(4-methylpiperazin-1-yl)propylamino]pyrimidin-4-yl]acetonitrile with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (2Z)-2-(3H-1,3-benzothiazol-2-ylidene)-2-[2-[3-(4-methylpiperazin-1-yl)propylamino]pyrimidin-4-yl]acetonitrile?
The IUPAC name of (2Z)-2-(3H-1,3-benzothiazol-2-ylidene)-2-[2-[3-(4-methylpiperazin-1-yl)propylamino]pyrimidin-4-yl]acetonitrile (CID 11181791) is (2Z)-2-(3H-1,3-benzothiazol-2-ylidene)-2-[2-[3-(4-methylpiperazin-1-yl)propylamino]pyrimidin-4-yl]acetonitrile.
What is the SMILES notation for (2Z)-2-(3H-1,3-benzothiazol-2-ylidene)-2-[2-[3-(4-methylpiperazin-1-yl)propylamino]pyrimidin-4-yl]acetonitrile?
The canonical SMILES for (2Z)-2-(3H-1,3-benzothiazol-2-ylidene)-2-[2-[3-(4-methylpiperazin-1-yl)propylamino]pyrimidin-4-yl]acetonitrile is CN1CCN(CCCNc2nccc(/C(C#N)=C3\Nc4ccccc4S3)n2)CC1.
What is the InChIKey of (2Z)-2-(3H-1,3-benzothiazol-2-ylidene)-2-[2-[3-(4-methylpiperazin-1-yl)propylamino]pyrimidin-4-yl]acetonitrile?
The InChIKey is BGZZNMJHBQOPLQ-CAPFRKAQSA-N. The full InChI is InChI=1S/C21H25N7S/c1-27-11-13-28(14-12-27)10-4-8-23-21-24-9-7-17(26-21)16(15-22)20-25-18-5-2-3-6-19(18)29-20/h2-3,5-7,9,25H,4,8,10-14H2,1H3,(H,23,24,26)/b20-16+.
What are the key properties of (2Z)-2-(3H-1,3-benzothiazol-2-ylidene)-2-[2-[3-(4-methylpiperazin-1-yl)propylamino]pyrimidin-4-yl]acetonitrile?
(2Z)-2-(3H-1,3-benzothiazol-2-ylidene)-2-[2-[3-(4-methylpiperazin-1-yl)propylamino]pyrimidin-4-yl]acetonitrile has a molecular weight of 407.55 g/mol, XLogP of 2.94, 6 rotatable bonds, 2 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for (2Z)-2-(3H-1,3-benzothiazol-2-ylidene)-2-[2-[3-(4-methylpiperazin-1-yl)propylamino]pyrimidin-4-yl]acetonitrile is sourced from PubChem (CID 11181791), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).